Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
Scope of the Report:
This report focuses on the Postmenopausal Vaginal Atrophy Treatment in China market, to split the market based on manufacturers, Regions (Province), type and application.
Market Segment by Manufacturers, this report covers
Pfizer
Allergan
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.
Market Segment by Regions (Province), covering
South China
Southwest China
East China
Northeast China
North China
Market Segment by Type, covers
Creams
Tablets
Patches
Rings
Market Segment by Applications, can be divided into
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy
There are 18 Chapters to deeply display the China Postmenopausal Vaginal Atrophy Treatment market.
Chapter 1, to describe Postmenopausal Vaginal Atrophy Treatment Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Postmenopausal Vaginal Atrophy Treatment, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4,to show the China market by Regions (Province),covering South China,East China,Southwest China,North China,Northeast China,Northwest China and Central China,with sales, price,revenue and market share of Postmenopausal Vaginal Atrophy Treatment,for each region,from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7,8,9,10,11,12 and 13 to analyze the key Province by Type and Application,covering South China,East China,Southwest China,North China,Northwest China,Central China and Northeast China,with sales,revenue and market share by types and applications;
Chapter 14, Postmenopausal Vaginal Atrophy Treatment market forecast, by Regions (Province), type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers etc.
Chapter 18, to describe Postmenopausal Vaginal Atrophy Treatment Appendix, methodology and data source
Frequently Asked Questions
Table Of Content
Table of Contents
1 Market Overview
1.1 Postmenopausal Vaginal Atrophy Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Creams
1.2.2 Tablets
1.2.3 Patches
1.2.4 Rings
1.3 Market Analysis by Applications
1.3.1 Topical Estrogen
1.3.2 Systemic Estrogen
1.3.3 Non-hormonal Therapy
1.4 Market Analysis by Regions (Province)
1.4.1 South China Status and Prospect (2012-2022)
1.4.2 Southwest China Status and Prospect (2012-2022)
1.4.3 East China Status and Prospect (2012-2022)
1.4.4 Northeast China Status and Prospect (2012-2022)
1.4.5 North China Status and Prospect (2012-2022)
1.4.6 Central China Status and Prospect (2012-2022)
1.4.7 Northwest China Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Profile
2.1.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Pfizer News
2.2 Allergan
2.2.1 Profile
2.2.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Allergan News
2.3 Shionogi
2.3.1 Profile
2.3.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Shionogi News
2.4 Novo Nordisk
2.4.1 Profile
2.4.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Novo Nordisk News
2.5 Teva Pharmaceutical
2.5.1 Profile
2.5.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Teva Pharmaceutical News
2.6 Bayer.
2.6.1 Profile
2.6.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Bayer. News
3 China Postmenopausal Vaginal Atrophy Treatment Market Competition, by Manufacturer
3.1 China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 China Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 China Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share
3.4.2 Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share
3.5 Market Competition Trend
4 China Postmenopausal Vaginal Atrophy Treatment Market Analysis by Regions (Province)
4.1 China Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Regions (Province)
4.2 China Postmenopausal Vaginal Atrophy Treatment Sales by Regions (Province) (2012-2017)
4.3 China Postmenopausal Vaginal Atrophy Treatment Revenue (Value) by Regions (Province) (2012-2017)
5 China Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Type
5.1 China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
5.1.2 China Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
5.2 Creams Sales Growth and Price
5.2.1 China Creams Sales Growth (2012-2017)
5.2.2 China Creams Price (2012-2017)
5.3 Tablets Sales Growth and Price
5.3.1 China Tablets Sales Growth (2012-2017)
5.3.2 China Tablets Price (2012-2017)
5.4 Patches Sales Growth and Price
5.4.1 China Patches Sales Growth (2012-2017)
5.4.2 China Patches Price (2012-2017)
5.5 Rings Sales Growth and Price
5.5.1 China Rings Sales Growth (2012-2017)
5.5.2 China Rings Price (2012-2017)
6 China Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Application
6.1 China Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
6.2 Topical Estrogen Sales Growth (2012-2017)
6.3 Systemic Estrogen Sales Growth (2012-2017)
6.4 Non-hormonal Therapy Sales Growth (2012-2017)
7 South China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
7.1 South China Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
7.2 South China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
7.3 South China Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
8 East China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
8.1 East China Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
8.2 East China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
8.3 East China Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
9 Southwest China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
9.1 Southwest China Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
9.2 Southwest China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
9.3 Southwest China Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
10 Northeast China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
10.1 Northeast China Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
10.2 Northeast China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
10.3 Northeast China Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
11 North China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
11.1 North China Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
11.2 North China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
11.3 North China Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
12 Central China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
12.1 Central China Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
12.2 Central China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
12.3 Central China Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
13 Northwest China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
13.1 Northwest China Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
13.2 Northwest China Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
13.3 Northwest China Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
14 Postmenopausal Vaginal Atrophy Treatment Market Forecast (2017-2022)
14.1 China Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022)
14.2 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Regions (Province) (2017-2022)
14.3 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Type (2017-2022)
14.4 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Application (2017-2022)
15 Postmenopausal Vaginal Atrophy Treatment Manufacturing Cost Analysis
15.1 Postmenopausal Vaginal Atrophy Treatment Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Analyst Introduction
19.3 Data Source
Inquiry For Buying
China Postmenopausal Vaginal Atrophy Treatment
Request Sample
China Postmenopausal Vaginal Atrophy Treatment
